Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
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
M1WyLDtsDhzH1eFv
